Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-07-12
2005-07-12
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C560S150000, C560S152000, C560S153000, C562S556000
Reexamination Certificate
active
06916850
ABSTRACT:
Certain known and novel pyruvate derivatives are particularly active in restoring or preserving metabolic integrity in oxidatively competent cells that have been subjected to oxygen deprivation. These pyruvate-derived compounds include, but are not limited to oximes, amides, pyruvate analogues, modified pyruvate analogues, esters of pyruvate (e.g., polyol-pyruvate esters, pyruvate thioesters, glycerol-pyruvate esters and dihydroxyacetone-pyruvate esters). Such pyruvate derivatives (including single tautomers, single stereoisomers and mixtures of tautomers and/or stereoisomers, and the pharmaceutically acceptable salts thereof) are useful in the manufacture of pharmaceutical compositions for treating a number of conditions characterized by oxidative stress.
REFERENCES:
patent: 4508729 (1985-04-01), Vincent et al.
patent: 5002963 (1991-03-01), De Luca et al.
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5210215 (1993-05-01), Politi et al.
patent: 5684185 (1997-11-01), Beck et al.
patent: 5719147 (1998-02-01), Dorn et al.
patent: 5736520 (1998-04-01), Bey et al.
patent: 5834588 (1998-11-01), Wasserman et al.
patent: 5859031 (1999-01-01), Hamilton et al.
patent: 5866604 (1999-02-01), Pellacini et al.
patent: 6184223 (2001-02-01), Kahn et al.
patent: 6221637 (2001-04-01), Hida et al.
patent: 6306887 (2001-10-01), Chupak et al.
patent: 6331537 (2001-12-01), Hamilton et al.
patent: 6348617 (2002-02-01), Ushio et al.
patent: 6410576 (2002-06-01), Nishimura et al.
patent: 0 417721 (1990-09-01), None
patent: 1 065 200 (2001-03-01), None
patent: WO 99/43651 (1999-02-01), None
patent: WO-0006594 (2000-02-01), None
patent: WO 01/25210 (2001-04-01), None
patent: WO 02/066672 (2002-08-01), None
patent: WO 02/074301 (2002-09-01), None
Wormhoudt et al., Drug metabolism and Disposition 26(5): 437-447, 1998.
Kinuta et al., Amino Acids 13(2): 163-169, 1997.
Commandeur et al., Chemical Research in Toxicology, 9(7): 1092-1102, 1996.
Machida et al., Physiological Chemistry and Physics and Medical NMR 27(3): 203-216, 1995.
Gilbert et al., Journal of American Chemical Society, 114(10): 3966-3973, 1992.
Hideo et al., Biochemical and Biophysical research Communications 155(3): 1119-1125,1988.
Scandurra et al., FEBBS Letters 231(1): 192-196, 1988.
Ricci et al., Analytical Biochemistry 142(1): 175-181,1994.
Ricci et al., Physiological Chemistry and Physics 14(3): 193-199, 1982.
Kolasa et al., Journal of Organic Chemistry 43: 690-705, 2000.
Hu, L. et al. (1990). “Inhibition of Cathepsin B and Papain by Peptidyl alpha-Keto Esters, alpha-Keto Amides, alpha-Diketones, and alpha-Keto Acids”Archives of Biochemistry and Biophysics281(2):271-274.
Bonnema, J., et al. (1960). “ Chemistry of Acetylenic Ethers XLIV”Recueil. 79:937-949.
Sokolov, M.P. et al. (1986). “Synthesis and Structure of Methyl 2-Oxo-3-Meslypropanoate”Journal of Organic Chemistry of the USSR. 22(4):644-647,.
Demina, L.M. et al. (1992). “Synthesis, properties, and biological activity of 2-substituted 1-aryl-7-methyl (5,7-dimethly)-4-oxy-1,4-dihydropyrido[2,3-d]pyrimideines”Khimiko-Farmatsevticheskii Zhurnal.26(3):45-48. (abstract).
Cavallini, D. et al, Progress in Clinical and Biological Research (1983) 125, 355-63.
Ricci, g. et al., Biochimica et Biophysica Acta (1983), 748 (1), 40-7.
Cavallini, D. et al., Advances in Experimental Medicine and Biology (1982), 148, 359-74.
Zhang, J. et al., Physiological Chemistry and Physics and Medical NMR (1997), 29(2), 199-211.
Dupre, S. et al., Biochemical and Biophysical Research Communications (1993), 195(2), 673-8.
Fontana, M. et al, Biochemical and Biophysical Research Communications (1990), 171 (1), 480-6.
Rossi, S. et al., Gazz. Chim. Ital., (1962) 92, 1367-78- Abstract only.
Strutov, I.T. et al., Zhur. Obschei Khim. (1958), 28, 69-71—Abstract only.
Miller Guy
Wang Bing
Zhang Wei
Balasubramanian Venkataraman
Galileo Pharmaceuticals, Inc.
Lowin David A.
Pfister Gloria
LandOfFree
Pyruvate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyruvate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyruvate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3374652